Rebecca Jackson
Rebecca Jackson’s career spans 20 years in the life sciences clinical research industry, predominantly within pharmaceutical R&D with focus on innovative technologies and novel trial modalities. Rebecca has extensive experience gained from sponsor, vendor and CRO perspectives and is an industry recognized authority in clinical trial technology and operations including electronic health record use in clinical research, decentralization of clinical trials, digital health and digital biomarkers, drug delivery solutions and innovation technologies such as applied and generative AI. A Life Sciences graduate of the Open University holding an MSc in Clinical Trials from the University of Edinburgh, Rebecca is an active participant across several industry groups, research collaborations and international industry initiatives and an acknowledged industry expert.
During her ten-year tenure at J&J, Rebecca has successfully lead M&A technology migrations, developed core technology strategies, driven spearhead innovation projects and positioned J&J as the industry leader in EHR data acquisition. Working across multiple Therapeutic Areas, Rebecca’s digital transformation leadership spans medical affairs, early and late development, global clinical operations, supply chain and global public health.